CN1043307C - Drug for exterior use for treating necrosis of femoral head - Google Patents
Drug for exterior use for treating necrosis of femoral head Download PDFInfo
- Publication number
- CN1043307C CN1043307C CN94114838A CN94114838A CN1043307C CN 1043307 C CN1043307 C CN 1043307C CN 94114838 A CN94114838 A CN 94114838A CN 94114838 A CN94114838 A CN 94114838A CN 1043307 C CN1043307 C CN 1043307C
- Authority
- CN
- China
- Prior art keywords
- radix
- femoral head
- medicine
- necrosis
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses an external-use medicine for treating femur head necrosis, which is prepared from the following Chinese-medicinal materials according to a certain proportion: 18 to 22g of eagle wood, 18 to 22g of rehmannia root, 18 to 22g of corydalis tuber, 18 to 22g of cinnabar, 28 to 32g of kudzuvine root, 28 to 32g of myrrh, 18 to 22g of draconis resin, 48 to 52g of crab, 18 to 22g of edible tulip, 18 to 22g of alkanna tinctoria, 18 to 22g of safflower, 18 to 22g of ructus viticis, 18 to 22g of leech.
Description
The present invention relates to a kind of medicine for external use for the treatment of osteonecrosis of femoral head, belong to the Chinese medicine formulation art.
Hip joint is one of human body six big joints, is that human repeating motion is maximum, and the maximum joint of femoral head carrying in case necrose, will become a great problem in the medical domain, be called " new cancer ".General traditional medical science viewpoint thinks that bone necrosis, particularly femur head necrosis can not repair, and is irreversible.Therefore replace artificial joint, substitute the main treatment means that has just become this disease with prosthese.Artificial femoral head replacement's infectious-related complication is difficult to overcome, and occur to infect, loosening, joint stiffness, pain etc., can cause patient's lifelong disability.Research to the femur head necrosis paathogenic factor, be commonly considered as the necrosis that blood supply disorder causes in the femoral head, under this theoretical direction, treatment means is a purpose to improve the blood supply environment, has occurred Therapeutic Method such as vascular transplant, muscle flap vessel pedicle transplantation, bone lobe dislocation art, fetus cartilage dislocation art, interventional therapy in succession.Tcm therapy is based on blood circulation promoting and blood stasis dispelling, bone and muscle strengthening, nourishing the liver and kidney, and external treatment adopts the plaster external application.Above-mentioned therapy is to reparation, the treatment of necrotic femoral head, and the throughput fractional analysis does not still have final conclusion at aspects such as pathology, histologys.
Rationale is breakthrough to be discovered, the femur head necrosis paathogenic factor is not ischemic femoral head and blood supply disorder, but ultrastructure changes in the femoral head, internal stress of bone changes, the piezoelectric property of bone and electrokinetic property disorder, the electrical environment disequilibrium produces potential difference.This electrical environment destroys reason medicine source property, mechanicalness and chemical reason.Therapeutic Method then to improve the bio electricity environment, restores balance it.According to this theory, the inventor invents and has developed Huang Shi therapeutic apparatus for femoral head necrosis (China Patent No. CN92111451.6), is applied to the patient and has obtained excellent curative, and in order to improve curative effect, the inventor has developed the serial Chinese medicine that cooperates this instrument to use.
The object of the invention then provides the medicine for external use that a kind of Huang Shi of cooperation femoral head therapeutic instrument uses.
Medicine of the present invention is that the Chinese medicine with following proportioning (weight ratio) is the medicine for external use that raw material is made:
Lignum Aquilariae Resinatum 18-22g Radix Rehmanniae 18-22g Rhizoma Corydalis 18-22g
Cinnabaris 18-22g Radix Puerariae 28-32g Myrrha 28-32g
Sanguis Draxonis 18-22g Eriocheir sinensis 48-52g Pseudobulbus cremastrae seu pleiones 18-22g
Radix Arnebiae (Radix Lithospermi) 18-22g Flos Carthami 18-22g Fructus Viticis 18-22g
Hirudo 18-22g
The preparation method of medicine for external use of the present invention is with the oven dry of above-mentioned raw materials medicine, is ground into smalls, packing, every bag 10g.
Medicine of the present invention and Huang Shi therapeutic apparatus for femoral head necrosis are used.During use with medicine of the present invention with gingerade furnishing pasty state, spread on the acupuncture point (occupy Liao, Xuanzhong, in all) with gauze effective components of Chinese medicinal imported in the femoral head, a twice-daily, each was a course of treatment in one time three months sooner or later.
Medicine of the present invention can be repaired the femoral head articular surface, improves the joint space, recovers hip joint function, can be used for treating femur head necrosis, hip joint hyperplasia, and arthralgia is stiff.
Medicine of the present invention in use uses through clinical 1027 examples, and 1782 hip joint treatments are analyzed, and total effective rate reaches 97.2%, and cure rate reaches 54.2%.Wherein:
1, improve hip joint function, take care of oneself, the hip joint activity is normal substantially, outer bend, interior receipts, bend hip, after stretch and reach positive physiological function scope person 842 examples, account for sum 41.5%
2, collapse of the femoral head, acetabular bone are destroyed, the joint stiffness patient removes sequestrum by treatment, the area of new bone structure occurs, and joint space improver 212 examples account for sum 11.9%.
3, pain relief, normal, the femoral head carrying improvement of terms of walking can be adhered to worker's 362 examples, accounts for sum 19.8%.
4, femur head necrosis is the sclerosis ischemic necrosis, the loose type patient of femoral head hypertrophy dwindles by the treatment femoral head, and improve the joint space, area of new bone girder person 126 examples occur, accounts for sum 7.3%.
5, femur head necrosis is molten bone destruction, a head distortion subluxation or a complete dislocation occur, also receives and resets through treating remaining femoral head, and sequestrum is removed, and newborn carrying bone trabecula improves the carrying environment, can the person's of taking care of oneself 137 examples, account for 7.9%.
6, femur head necrosis has been replaced artificial joint, pain and is liied in bed unbearably and can not walk, and through the treatment pain relief, can hold and turn walker 18 examples, accounts for sum 1.05%.
7, femur head necrosis underwent operative treatment, joint capsule destroyed hip joint structure biomechanics occurs and change, and nonresponder's 49 examples account for sum 2.8%.
Embodiment:
Composition of raw materials is as follows
Lignum Aquilariae Resinatum 20g Radix Rehmanniae 20g Rhizoma Corydalis 20g Cinnabaris 20g Radix Puerariae 30g
Myrrha 20g Sanguis Draxonis 20g Eriocheir sinensis 50g Pseudobulbus cremastrae seu pleiones 20g Radix Arnebiae (Radix Lithospermi) 20g
Flos Carthami 20g Fructus Viticis 20g Hirudo (processing) 20g
With above-mentioned medical material oven dry, be ground into fine flour, packing, every bag 10g.
Claims (2)
1, a kind of medicine for the treatment of femur head necrosis is characterized in that it is the topical agent made from following proportion raw material:
Lignum Aquilariae Resinatum 18-22g Radix Rehmanniae 18-22g Rhizoma Corydalis 18-22g
Cinnabaris 18-22g Radix Puerariae 28-32g Myrrha 28-32g
Sanguis Draxonis 18-22g Eriocheir sinensis 48-52g Pseudobulbus cremastrae seu pleiones 18-22g
Radix Arnebiae (Radix Lithospermi) 18-22g Flos Carthami 18-22g Fructus Viticis 18-22g
Hirudo 18-22g
2,, it is characterized in that it is the topical agent made from following proportion raw material according to the medicine of claim 1:
Lignum Aquilariae Resinatum 20g Radix Rehmanniae 20g Rhizoma Corydalis 20g Cinnabaris 20g Radix Puerariae 30g
Myrrha 20g Sanguis Draxonis 20g Eriocheir sinensis 50g Pseudobulbus cremastrae seu pleiones 20g Radix Arnebiae (Radix Lithospermi) 20g
Flos Carthami 20g Fructus Viticis 20g Hirudo (processing) 20g
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94114838A CN1043307C (en) | 1994-08-13 | 1994-08-13 | Drug for exterior use for treating necrosis of femoral head |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94114838A CN1043307C (en) | 1994-08-13 | 1994-08-13 | Drug for exterior use for treating necrosis of femoral head |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1121817A CN1121817A (en) | 1996-05-08 |
| CN1043307C true CN1043307C (en) | 1999-05-12 |
Family
ID=5037212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN94114838A Expired - Fee Related CN1043307C (en) | 1994-08-13 | 1994-08-13 | Drug for exterior use for treating necrosis of femoral head |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1043307C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1056994C (en) * | 1997-10-06 | 2000-10-04 | 王令喜 | External-use ointment for treating necrosis of head of femur |
| CN1076617C (en) * | 1999-06-16 | 2001-12-26 | 王松彪 | Medicine specially for treating caput femoris necrosis, and method for preparing same |
| CN1101219C (en) * | 1999-12-09 | 2003-02-12 | 张印昌 | Chinese-medicinal pills for treating ischemic necrosis of femur head |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1089164A (en) * | 1993-10-30 | 1994-07-13 | 王占礼 | The Chinese medicine preparation and the method for making thereof of treatment femoral head necrosis |
-
1994
- 1994-08-13 CN CN94114838A patent/CN1043307C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1089164A (en) * | 1993-10-30 | 1994-07-13 | 王占礼 | The Chinese medicine preparation and the method for making thereof of treatment femoral head necrosis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1121817A (en) | 1996-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1389252A (en) | Composite medicine for treating femoral head necrosis | |
| CN1895332A (en) | Oral and externally-applied Chinese medicinal preparation for treating osteoproliferation and its production | |
| CN105982976A (en) | Osteal penetrant for treating osteoarticular diseases and preparation method thereof | |
| CN1189201C (en) | Externally applied Chinese medicine for treating osteoarthropathy and its prepn process | |
| CN1043307C (en) | Drug for exterior use for treating necrosis of femoral head | |
| CN1054520C (en) | Drug for exterior use for treating necrosis of femoral head | |
| CN1049133C (en) | Oral medicine for treating necrosis of femoral head | |
| CN1043308C (en) | Drug for exterior use for treating necrosis of femoral head | |
| CN1284580C (en) | Bone Activating stasis transforming capsule | |
| CN110840861B (en) | Cervical vertebra plaster for clearing and activating channels and collaterals, and preparation method and application thereof | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN109432309B (en) | Traditional Chinese medicine composition, external medicinal liquor, and preparation method and application thereof | |
| CN1063650C (en) | Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method | |
| CN1443550A (en) | Chinese medicine for curing necrosis of femoral head | |
| CN1076614C (en) | Exterior-applied powder medicine for treating lumbar intervertebral disk protrusion and preparing process | |
| CN111407815A (en) | Ointment for treating lumbar intervertebral disc and osteodynia and preparation method thereof | |
| CN108888736B (en) | External-use bone reunion medicine and preparation method thereof | |
| CN1250245C (en) | Capsule for treating osteonecrosis and bone fracture | |
| CN1636578A (en) | Chinese kmedicine bolus for treating femoral head necrosis and its prepn process | |
| CN108815415B (en) | Externally-applied medicine for treating rheumatic ostealgia and preparation method thereof | |
| CN101181570B (en) | Externally used detumescence pain-relieving medical ointment for curing orthopaedics illness | |
| CN1050289C (en) | Quick-acting antirheumatic | |
| CN1258533A (en) | Rheumatism-treating medical liquor | |
| CN1294953C (en) | External Chinese materia medica preparation for treating leucoderma | |
| CN1058867C (en) | Drug composite for curing bone tuberculosis in fumigation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |